Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique

Sponsor
Beth Israel Deaconess Medical Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02271100
Collaborator
(none)
110
1
2
74.2
1.5

Study Details

Study Description

Brief Summary

This study is intended to determine whether ultrasound imaging can improve the ability to place a spinal or epidural needle in obstetric anesthesia. By evaluating the use of ultrasound for the placement of epidural catheters the investigators hope to answer two questions:

  1. How does the traditional technique based on palpation compare to one using ultrasound to place an epidural catheter? 2. Does ultrasound reduce one potential risk in epidural placement?
Condition or Disease Intervention/Treatment Phase
  • Device: ultrasound guidance
  • Device: palpation guidance
N/A

Detailed Description

This study contains two phases:
  1. A prospective, randomized, blinded comparison of ultrasound imaging versus palpation for epidural catheter insertion in laboring women.

  2. A prospective, single cohort, blinded trial to assess whether ultrasound imaging provides a reliable placement below the L3 vertebra.

The initial phase of the investigation will be a randomized comparison of ultrasound versus palpation. Patients will be enrolled in early labor and will be randomized to have their epidural placed with either technique. The technique will be chosen by computer-generated randomization list maintained in opaque sequentially numbered envelopes. Description of the placement technique is below. The primary outcome will be the number of epidural catheters inserted above the intended insertion site. The investigators will also assess the total time required for epidural catheter placement, number of attempts for successful insertion, effectiveness of the epidural catheter for labor pain control.

Following completion of enrollment of the first phase, the second phase of the investigation will enroll patients only into the single-cohort ultrasound arm. The study will use the same methodology as the initial phase, but without randomization due to a single cohort. The primary outcome will be the absolute number of epidural catheters inserted above the L3 vertebral body. The investigators will also assess the effectiveness of the ultrasound markings for guiding placement.

Procedure placement technique After written, informed consent, and standard patient preparation, the epidural catheter will be placed with the patient in the sitting position by a junior resident. In the ultrasound arm, the patient will be first imaged using an appropriate probe, and the identified ultrasound landmarks marked on the skin. The skin will be prepped in the usual fashion, and the needle will be inserted at the identified site and direction determined by ultrasound. In the palpation arm, the skin will be prepped and the needle will be inserted using palpation-identified landmarks to guide the needle. All catheters will be intended to be placed at the L4-L5 interspace as the primary attempt. The L3-L4 interspace will be used as a secondary attempt.

Assessment of final position After insertion of the epidural catheter and administration of the pain relief medication, patients in both groups will be examined by a blinded observer using ultrasound to determine the catheter insertion site and the likely insertion interspace.

If, however, the investigators discover that the use of ultrasound for placement of the epidural catheter may present greater risk than previously anticipated to the pregnant woman or fetus, then the investigators will stop the study after phase 1 and not proceed with phase 2.

Study Design

Study Type:
Interventional
Actual Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized blinded comparison of two methods to identify landmarks for a procedurerandomized blinded comparison of two methods to identify landmarks for a procedure
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique
Actual Study Start Date :
Oct 25, 2016
Actual Primary Completion Date :
Dec 31, 2019
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: palpation guidance

placement of spinal or combined spinal epidural needle using palpation to guide entry position

Device: palpation guidance
use of palpation for position estimation

Active Comparator: ultrasound guidance

placement of spinal or combined spinal epidural using ultrasound to guide entry position

Device: ultrasound guidance
use of ultrasound for entry position estimation

Outcome Measures

Primary Outcome Measures

  1. Placement below L3 vertebra [immediate]

    Percentage of catheters placed below the target location

Secondary Outcome Measures

  1. Time to placement [immediate]

    Minutes from start of procedure to the end of the procedure

  2. Success of the epidural catheter placement [immediate]

    Relief of labor pain defined by verbal pain score less than 4 after administration of medication

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy ASA I or II parturient

  • Will be receiving neuraxial placement for labor, having been consented for the procedure

Exclusion Criteria:
  • ASA III or IV

  • Unable to participate in the study due to severe pain

  • Contraindications to neuraxial analgesia

  • Previous spinal surgery in the lumbar or sacral area (L1 through Sacrum)

  • BMI greater than 37

  • Height less than 60 inches

  • Significant scoliosis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beth Isreal Deaconess Medical Center Boston Massachusetts United States 02215

Sponsors and Collaborators

  • Beth Israel Deaconess Medical Center

Investigators

  • Principal Investigator: Philip E Hess, MD, Beth Israel Deaconess Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Phillip Hess, MD, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT02271100
Other Study ID Numbers:
  • 2014P000267
First Posted:
Oct 22, 2014
Last Update Posted:
May 11, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2021